Mary E Lacy1, Gregory A Wellenius2, Mercedes R Carnethon3, Eric B Loucks2, April P Carson4, Xi Luo5, Catarina I Kiefe6, Annie Gjelsvik2, Erica P Gunderson7, Charles B Eaton2, Wen-Chih Wu8. 1. Department of Epidemiology, School of Public Health, Brown University, Providence, RI Center of Innovation in Long-Term Services and Supports, Providence Veterans Affairs Medical Center, Providence, RI mary_lacy@brown.edu. 2. Department of Epidemiology, School of Public Health, Brown University, Providence, RI. 3. Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL. 4. Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL. 5. Department of Biostatistics, School of Public Health, Brown University, Providence, RI. 6. Department of Qualitative Health Sciences, University of Massachusetts Medical School, Worcester, MA. 7. Cardiovascular and Metabolic Conditions Section, Division of Research, Kaiser Permanente Northern California, Oakland, CA. 8. Department of Epidemiology, School of Public Health, Brown University, Providence, RI Center of Innovation in Long-Term Services and Supports, Providence Veterans Affairs Medical Center, Providence, RI Division of Cardiology, Providence Veterans Affairs Medical Center, Providence, RI.
Abstract
OBJECTIVE: In 2010, the American Diabetes Association (ADA) added hemoglobin A1c (A1C) to the guidelines for diagnosing type 2 diabetes. However, existing models for predicting diabetes risk were developed prior to the widespread adoption of A1C. Thus, it remains unknown how well existing diabetes risk prediction models predict incident diabetes defined according to the ADA 2010 guidelines. Accordingly, we examined the performance of an existing diabetes prediction model applied to a cohort of African American (AA) and white adults from the Coronary Artery Risk Development Study in Young Adults (CARDIA). RESEARCH DESIGN AND METHODS: We evaluated the performance of the Atherosclerosis Risk in Communities (ARIC) diabetes risk prediction model among 2,456 participants in CARDIA free of diabetes at the 2005-2006 exam and followed for 5 years. We evaluated model discrimination, calibration, and integrated discrimination improvement with incident diabetes defined by ADA 2010 guidelines before and after adding baseline A1C to the prediction model. RESULTS: In the overall cohort, re-estimating the ARIC model in the CARDIA cohort resulted in good discrimination for the prediction of 5-year diabetes risk (area under the curve [AUC] 0.841). Adding baseline A1C as a predictor improved discrimination (AUC 0.841 vs. 0.863, P = 0.03). In race-stratified analyses, model discrimination was significantly higher in whites than AA (AUC AA 0.816 vs. whites 0.902; P = 0.008). CONCLUSIONS: Addition of A1C to the ARIC diabetes risk prediction model improved performance overall and in racial subgroups. However, for all models examined, discrimination was better in whites than AA. Additional studies are needed to further improve diabetes risk prediction among AA.
OBJECTIVE: In 2010, the American Diabetes Association (ADA) added hemoglobin A1c (A1C) to the guidelines for diagnosing type 2 diabetes. However, existing models for predicting diabetes risk were developed prior to the widespread adoption of A1C. Thus, it remains unknown how well existing diabetes risk prediction models predict incident diabetes defined according to the ADA 2010 guidelines. Accordingly, we examined the performance of an existing diabetes prediction model applied to a cohort of African American (AA) and white adults from the Coronary Artery Risk Development Study in Young Adults (CARDIA). RESEARCH DESIGN AND METHODS: We evaluated the performance of the Atherosclerosis Risk in Communities (ARIC) diabetes risk prediction model among 2,456 participants in CARDIA free of diabetes at the 2005-2006 exam and followed for 5 years. We evaluated model discrimination, calibration, and integrated discrimination improvement with incident diabetes defined by ADA 2010 guidelines before and after adding baseline A1C to the prediction model. RESULTS: In the overall cohort, re-estimating the ARIC model in the CARDIA cohort resulted in good discrimination for the prediction of 5-year diabetes risk (area under the curve [AUC] 0.841). Adding baseline A1C as a predictor improved discrimination (AUC 0.841 vs. 0.863, P = 0.03). In race-stratified analyses, model discrimination was significantly higher in whites than AA (AUC AA 0.816 vs. whites 0.902; P = 0.008). CONCLUSIONS: Addition of A1C to the ARIC diabetes risk prediction model improved performance overall and in racial subgroups. However, for all models examined, discrimination was better in whites than AA. Additional studies are needed to further improve diabetes risk prediction among AA.
Authors: Julienne K Kirk; Ralph B D'Agostino; Ronny A Bell; Leah V Passmore; Denise E Bonds; Andrew J Karter; K M Venkat Narayan Journal: Diabetes Care Date: 2006-09 Impact factor: 19.112
Authors: David C Ziemer; Paul Kolm; William S Weintraub; Viola Vaccarino; Mary K Rhee; Jennifer G Twombly; K M Venkat Narayan; David D Koch; Lawrence S Phillips Journal: Ann Intern Med Date: 2010-06-15 Impact factor: 25.391
Authors: Jean N Utumatwishima; Rafeal L Baker; Brianna A Bingham; Stephanie T Chung; David Berrigan; Anne E Sumner Journal: J Racial Ethn Health Disparities Date: 2017-04-25
Authors: Stephanie T Chung; Amber B Courville; Anthony U Onuzuruike; Mirella Galvan-De La Cruz; Lilian S Mabundo; Christopher W DuBose; Kannan Kasturi; Hongyi Cai; Ahmed M Gharib; Peter J Walter; H Martin Garraffo; Shaji Chacko; Morey W Haymond; Anne E Sumner Journal: JCI Insight Date: 2018-09-20
Authors: Benjamin D Pollock; Tian Hu; Wei Chen; Emily W Harville; Shengxu Li; Larry S Webber; Vivian Fonseca; Lydia A Bazzano Journal: J Diabetes Complications Date: 2016-07-27 Impact factor: 2.852
Authors: Linda J Andes; Yiling J Cheng; Deborah B Rolka; Edward W Gregg; Giuseppina Imperatore Journal: JAMA Pediatr Date: 2020-02-03 Impact factor: 16.193
Authors: Regine Mugeni; Jessica Y Aduwo; Sara M Briker; Thomas Hormenu; Anne E Sumner; Margrethe F Horlyck-Romanovsky Journal: Front Endocrinol (Lausanne) Date: 2019-10-01 Impact factor: 5.555
Authors: Aaron Leong; Natalie Daya; Bianca Porneala; James J Devlin; Dov Shiffman; Michael J McPhaul; Elizabeth Selvin; James B Meigs Journal: Diabetes Care Date: 2017-10-26 Impact factor: 19.112